Has Julie Keegan Strosser received payments from drug or device companies?

Yes. Drug and device makers reported $8,143 in general payments to Julie Keegan Strosser across 334 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Julie Keegan Strosser did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Julie Keegan Strosser come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Julie Keegan Strosser

Physician Assistant · Aventura, FLNPI 1780997734

Payments from drug & device makers

$8,143in general payments, 2019–2025

Across 334 payments — averaging $24.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
AstraZeneca$979
Amgen$893
GSK$642
Aurinia Pharma U.S., Inc.$600
Pfizer$491
plus $3K from 21 others

What the payments were for

Consulting fees$5957%
Food & beverage$7,40891%
Education$1412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	51	$1,232
AstraZeneca(2 entities)	22	$979
Amgen(2 entities)	47	$893
GSK	32	$642
Aurinia Pharma U.S., Inc.	28	$600
Pfizer	25	$491
Mallinckrodt Hospital Products Inc.	22	$449
ANI Pharmaceuticals, Inc.	16	$427
Radius Health, Inc.	16	$364
Intrinsiq Specialty Solutions, Inc.	3	$363
Novartis	9	$325
Johnson & Johnson(2 entities)	10	$259
Lilly USA, LLC	8	$155
UCB, Inc.	8	$151
Alvogen Inc	7	$149
Tersera Therapeutics LLC	3	$102
E.r. Squibb & Sons, L.L.C.	5	$100
Sanofi	4	$82
Takeda Pharmaceuticals U.S.A., Inc.	4	$77
Organon	4	$59
Octapharma USA, Inc.	3	$57
Sanofi-aventis U.S. LLC	1	$55
Fresenius Kabi USA, LLC	2	$40
CSL Behring	1	$27
Pacira Therapeutics, Inc.	1	$22
Boehringer Ingelheim	1	$21
Sandoz	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COSENTYX$132
TEPEZZA$124

How this compares

$8,143 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enbrel SureclickEtanercept	33	$244,046
KevzaraSarilumab	40	$175,630
Actemra ActpenTocilizumab	27	$129,996
RinvoqUpadacitinib	18	$117,850
Humira(Cf) PenAdalimumab	14	$94,148
ProliaDenosumab	51	$87,311
Cosentyx Sensoready (2 Pens)Secukinumab	12	$85,565
Humira PenAdalimumab	12	$83,496
BenlystaBelimumab	13	$73,063
ActemraTocilizumab	13	$61,475
Evenity (2 Syringes)Romosozumab-Aqqg	13	$31,930
Hydroxychloroquine Sulfate	132	$4,679
MethotrexateMethotrexate Sodium	219	$4,621
Lidocaine	33	$3,191
Azathioprine	47	$2,857

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
SanofiKevzara	$82	$175,63040 claims
AmgenProlia, Evenity (2 Syringes)	$893	$119,24164 claims
AbbVieRinvoq	$1,232	$117,85018 claims
GSKBenlysta	$642	$73,06313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Aventura

Richard MarshallPort Orange$988K
Audrey BeckerSt Augustine$689K
Kevin WilliamsTampa$647K
Brian BonomoLecanto$559K
Melissa SingletonOcala$482K
Reeli ReinuMaitland$427K
Jeanelle KingMiami$424K
Risha BellomoOrlando$397K
Jason BergerClearwater$344K
Ashley MillerGainesville$328K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →